Center for Scientific Review; Notice of Closed Meetings, 54638-54640 [2010-22311]
Download as PDF
<![CDATA[
jlentini on DSKJ8SOYB1PROD with NOTICES
54638
Federal Register / Vol. 75, No. 173 / Wednesday, September 8, 2010 / Notices
approval (PMA) requirements (section
515 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360e)).
On December 4, 2000, at a public
meeting of FDA’s Circulatory System
Devices Panel (the Panel), the Panel
recommended that PTCA catheters,
other than cutting/scoring PTCA
catheters and standard PTCA catheters
for the treatment of in-stent restenosis
and/or post-deployment stent
expansion, be reclassified from class III
to class II, when indicated for balloon
dilatation of a hemodynamically
significant coronary artery or bypass
graft stenosis in patients evidencing
coronary ischemia for the purpose of
improving myocardial perfusion, or for
treatment of acute myocardial
infarction. The Panel recommended a
guidance document, labeling, and
postmarket surveillance as special
controls.
FDA considered the Panel’s
recommendations and, on May 30, 2008,
published a proposed rule to reclassify
certain PTCA catheters, including
standard PTCA catheters for the
treatment of in-stent restenosis and/or
post-deployment stent expansion, but
not cutting/scoring PTCA catheters, into
class II. In addition, FDA issued a draft
class II special controls guidance
document entitled ‘‘Class II Special
Controls Guidance Document for
Certain Percutaneous Transluminal
Coronary Angioplasty (PTCA)
Catheters’’ to support the proposed
reclassification.
Following publication of the draft
guidance, two sets of comments on the
guidance were submitted to the FDA.
The comments received sought minor
clarifications on several pre-clinical
testing recommendations, including
biocompatibility, shelf-life and
performance testing. We considered the
suggestions and made appropriate
revisions. In addition, the guidance was
updated to include more specific
recommendations regarding evaluation
of coating integrity. FDA is now
identifying the guidance document
entitled ‘‘Class II Special Controls
Guidance Document for Certain
Percutaneous Transluminal Coronary
Angioplasty (PTCA) Catheters’’ as the
guidance document that will serve as
the special control for this device type.
The guidance document provides a
means by which PTCA catheters, other
than cutting/scoring PTCA catheters,
may comply with the requirement of
special controls for this class II device.
Following the effective date of the final
reclassification rule, any firm
submitting a premarket notification
(510(k)) for a PTCA catheter will need
to address the issues covered in the
VerDate Mar<15>2010
16:41 Sep 07, 2010
Jkt 220001
special controls guidance document.
However, the firm need only show that
its device meets the recommendations
of the guidance document or in some
other way provides equivalent
assurances of safety and effectiveness.
II. Significance of Guidance
This guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The guidance represents the agency’s
current thinking on standard PTCA
catheters. It does not create or confer
any rights for or on any person and does
not operate to bind FDA or the public.
An alternative approach may be used if
such approach satisfies the
requirements of the applicable statute
and regulations.
III. Electronic Access
Persons interested in obtaining a copy
of the guidance may do so by using the
Internet. To receive ‘‘Class II Special
Controls Guidance Document for
Certain Percutaneous Transluminal
Coronary Angioplasty (PTCA)
Catheters’’ you may either send an email request to dsmica@fda.hhs.gov to
receive an electronic copy of the
document or send a fax request to 301–
847–8149 to receive a hard copy. Please
use the document number (1608) to
identify the guidance you are
requesting.
CDRH maintains an entry on the
Internet for easy access to information
including text, graphics, and files that
may be downloaded to a personal
computer with Internet access. Updated
on a regular basis, the CDRH home page
includes device safety alerts, Federal
Register reprints, information on
premarket submissions (including lists
of approved applications and
manufacturers’ addresses), small
manufacturer’s assistance, information
on video conferencing and electronic
submissions, Mammography Matters,
and other device-oriented information.
The CDRH Web site may be accessed at
https://www.fda.gov/cdrh. A search
capability for all CDRH guidance
documents is available at https://
www.fda.gov/cdrh/guidance.html.
Guidance documents are also available
on the Division of Dockets Management
Internet site at https://
www.regulations.gov.
IV. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
3520). The collections of information in
21 CFR part 807, Subpart E, have been
approved under OMB control number
0910–0120; the collections of
information in 21 CFR part 812 have
been approved under OMB control
number 0910–0078; the collections of
information under CFR parts 50 and 56
have been approved under OMB control
number 0910–0130; the collections of
information in 21 CFR part 820 have
been approved under 0910–0073; and
the collections of information in 21 CFR
part 801 have been approved under
OMB control number 0910–0485.
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES), electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: August 31, 2010.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices
and Radiological Health.
[FR Doc. 2010–22303 Filed 9–7–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Selected
Topics in Transfusion Medicine.
Date: September 27–28, 2010.
Time: 8 a.m. to 5 p.m.
E:\FR\FM\08SEN1.SGM
08SEN1
jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 173 / Wednesday, September 8, 2010 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Bukhtiar H. Shah, DVM,
PhD, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120,
MSC 7802, Bethesda, MD 20892. (301) 435–
1233. shahb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Pain and Chemosensory Systems.
Date: September 29–30, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: John Bishop, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892. (301) 408–
9664. bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Dermatology.
Date: October 1, 2010.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: Richard Ingraham, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7814, Bethesda, MD 20892. 301–496–
8551. ingrahamrh@mail.nih.gov.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group, Neurotechnology
Study Section.
Date: October 4, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Savoy Suites, 2505 Wisconsin
Avenue, NW., Washington, DC 20007.
Contact Person: Robert C. Elliott, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892. 301–435–
3009. elliotro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neurotechnology 3.
Date: October 4, 2010.
Time: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Savoy Suites, 2505 Wisconsin
Avenue, NW., Washington, DC 20007.
Contact Person: Robert C. Elliott, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892. 301–435–
3009. elliotro@csr.nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
VerDate Mar<15>2010
16:41 Sep 07, 2010
Jkt 220001
Review Group, Molecular
Neuropharmacology and Signaling Study
Section.
Date: October 7–8, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue, NW., Washington, DC 20037.
Contact Person: Deborah L. Lewis, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183,
MSC 7850, Bethesda, MD 20892. 301–408–
9129. lewisdeb@csr.nih.gov.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group, Molecular
Neurogenetics Study Section.
Date: October 7–8, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Paek-Gyu Lee, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5203,
MSC 7812, Bethesda, MD 20892. (301) 435–
0902. leepg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Neurotechnology Overflow.
Date: October 12–13, 2010.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Savoy Suites, 2505 Wisconsin
Avenue, NW., Washington, DC 20007.
Contact Person: Robert C. Elliott, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190,
MSC 7846, Bethesda, MD 20892. 301–435–
3009. elliotro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Shared
Instrumentation: Neurotechnology.
Date: October 13, 2010.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Savoy Suites, 2505 Wisconsin
Avenue, NW., Washington, DC 20007.
Contact Person: Robert C. Elliott, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892. 301–435–
3009. elliotro@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Social
Science and Population Studies: R03s, R15s,
and R21s.
Date: October 14, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Guest Suites Santa
Monica, 1707 Fourth Street, Santa Monica,
CA 90401.
Contact Person: Suzanne Ryan, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
54639
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892. (301) 435–
1712. ryansj@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group, Macromolecular Structure
and Function E Study Section.
Date: October 14, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle, NW., Washington, DC 20005.
Contact Person: Nitsa Rosenzweig, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1102,
MSC 7760, Bethesda, MD 20892. (301) 435–
1747. rosenzweign@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group, Cardiovascular Differentiation and
Development Study Section.
Date: October 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Churchill Hotel, 1914 Connecticut
Avenue, NW., Washington, DC 20009.
Contact Person: Maqsood A Wani, PhD,
DVM, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136,
MSC 7814, Bethesda, MD 20892. 301–435–
2270. wanimaqs@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Innate Immunity
and Inflammation Study Section.
Date: October 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Old Town Alexandria, 1767
King Street, Alexandria, VA 22314.
Contact Person: Tina McIntyre, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892. 301–594–
6375. mcintyrt@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group, Acute Neural Injury and Epilepsy
Study Section.
Date: October 14–15, 2010.
Time: 8 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle, NW., Washington, DC 20005.
Contact Person: Seetha Bhagavan, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892. (301) 237–
9838. bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Development Methods of In Vivo Imaging
and Bioengineering Research.
Date: October 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\08SEN1.SGM
08SEN1
jlentini on DSKJ8SOYB1PROD with NOTICES
54640
Federal Register / Vol. 75, No. 173 / Wednesday, September 8, 2010 / Notices
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Behrouz Shabestari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7854, Bethesda, MD 20892. (301) 435–
2409. shabestb@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group,
Molecular Oncogenesis Study Section.
Date: October 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Old Town Alexandria,
901 North Fairfax Street, Alexandria, VA
22314.
Contact Person: Nywana Sizemore, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204,
MSC 7804, Bethesda, MD 20892. 301–435–
1718. sizemoren@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group, Nuclear and
Cytoplasmic Structure/Function and
Dynamics Study Section.
Date: October 14–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The St. Regis Washington, DC, 923
16th and K Streets, NW., Washington, DC
20006.
Contact Person: David Balasundaram, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892. 301–435–
1022. balasundaramd@csr.nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group,
Pathogenic Eukaryotes Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Tera Bounds, DVM, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892. 301–435–
2306. boundst@csr.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group, International and Cooperative
Projects—1 Study Section.
Date: October 14, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Dan D. Gerendasy, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5132,
MSC 7843, Bethesda, MD 20892. 301–594–
6830. gerendad@csr.nih.gov.
VerDate Mar<15>2010
16:41 Sep 07, 2010
Jkt 220001
Name of Committee: Immunology
Integrated Review Group, Immunity and Host
Defense Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Old Town Alexandria, 1767
King Street, Alexandria, VA 22314.
Contact Person: Patrick K. Lai, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2215,
MSC 7812, Bethesda, MD 20892. 301–435–
1052. laip@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group,
Therapeutic Approaches to Genetic Diseases.
Date: October 14, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue, NW., Washington, DC 20037.
Contact Person: Michael K. Schmidt, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2214,
MSC 7890, Bethesda, MD 20892. (301) 435–
1147. mschmidt@mail.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Cellular and
Molecular Immunology—B Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Magnificent Mile
Downtown Chicago, 165 E. Ontario Street,
Chicago, IL 60611.
Contact Person: Betty Hayden, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892. 301–435–
1223. haydenb@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group, Genetic
Variation and Evolution Study Section.
Date: October 14–15, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The River Inn, 924 25th Street, NW.,
Washington, DC 20037.
Contact Person: David J. Remondini, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210,
MSC 7890, Bethesda, MD 20892. 301–435–
1038. remondid@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: SAT and BTSS Study Sections.
Date: October 14, 2010.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting).
Contact Person: Roberto J. Matus, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
MSC 7854, Bethesda, MD 20892. (301) 435–
2204. matusr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 1, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–22311 Filed 9–7–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of a Meeting of a Working
Group of the NIH Blue Ribbon Panel
The purpose of this notice is to inform
the public about a meeting of the NIH
Blue Ribbon Panel to Advise on the Risk
Assessment of the National Emerging
Infectious Diseases Laboratories at the
Boston University Medical Campus. The
meeting will be held Tuesday, October
5, 2010 at the Mainstage at Roxbury
Community College, 1234 Columbus
Avenue, Roxbury, MA from
approximately 6:30 p.m. to 10 p.m.
This public meeting is being held to
provide an update to the community on
the status and proposed approach of the
risk assessment for the BUMC NEIDL.
The meeting program will include an
update and review of the ongoing
supplementary risk assessment study as
well as opportunity for oral public
comment. In addition, at any time,
members of the public may file written
comments to the following address: NIH
Blue Ribbon Panel, Office of the
Director, National Institutes of Health,
Mail Stop Code 7985, Bethesda, MD
20892–7985 or by sending an e-mail to:
nih_brp@od.nih.gov.
An agenda and slides for the meeting
will be posted to the NIH Blue Ribbon
Panel Web site in advance of the
meeting at: https://nihblueribbonpanelbumc-neidl.od.nih.gov/. For additional
information concerning this meeting,
contact Ms. Kelly Fennington, Senior
Health Policy Analyst, Office of
Biotechnology Activities, Office of
Science Policy, Office of the Director,
National Institutes of Health, 6705
Rockledge Drive, Room 750, Bethesda,
MD 20892–7985; telephone 301–496–
9838; e-mail fennington@nih.gov.
E:\FR\FM\08SEN1.SGM
08SEN1
]]>Agencies
[Federal Register Volume 75, Number 173 (Wednesday, September 8, 2010)]
[Notices]
[Pages 54638-54640]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-22311]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Selected Topics in Transfusion Medicine.
Date: September 27-28, 2010.
Time: 8 a.m. to 5 p.m.
[[Page 54639]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
Contact Person: Bukhtiar H. Shah, DVM, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4120, MSC 7802, Bethesda, MD
20892. (301) 435-1233. shahb@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Pain and Chemosensory Systems.
Date: September 29-30, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting.)
Contact Person: John Bishop, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892. (301) 408-
9664. bishopj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: Dermatology.
Date: October 1, 2010.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call.)
Contact Person: Richard Ingraham, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD
20892. 301-496-8551. ingrahamrh@mail.nih.gov.
Name of Committee: Emerging Technologies and Training
Neurosciences Integrated Review Group, Neurotechnology Study
Section.
Date: October 4, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Savoy Suites, 2505 Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Robert C. Elliott, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD
20892. 301-435-3009. elliotro@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Neurotechnology 3.
Date: October 4, 2010.
Time: 4 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Savoy Suites, 2505 Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Robert C. Elliott, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD
20892. 301-435-3009. elliotro@csr.nih.gov.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group, Molecular Neuropharmacology
and Signaling Study Section.
Date: October 7-8, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Avenue, NW., Washington,
DC 20037.
Contact Person: Deborah L. Lewis, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD
20892. 301-408-9129. lewisdeb@csr.nih.gov.
Name of Committee: Emerging Technologies and Training
Neurosciences Integrated Review Group, Molecular Neurogenetics Study
Section.
Date: October 7-8, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC
20036.
Contact Person: Paek-Gyu Lee, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5203, MSC 7812, Bethesda, MD 20892. (301) 435-
0902. leepg@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Neurotechnology Overflow.
Date: October 12-13, 2010.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: Savoy Suites, 2505 Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Robert C. Elliott, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190, MSC 7846, Bethesda, MD
20892. 301-435-3009. elliotro@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Shared Instrumentation: Neurotechnology.
Date: October 13, 2010.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Savoy Suites, 2505 Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Robert C. Elliott, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130, MSC 7850, Bethesda, MD
20892. 301-435-3009. elliotro@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Social Science and Population Studies: R03s, R15s, and R21s.
Date: October 14, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Doubletree Guest Suites Santa Monica, 1707 Fourth Street,
Santa Monica, CA 90401.
Contact Person: Suzanne Ryan, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3139, MSC 7770, Bethesda, MD 20892. (301) 435-
1712. ryansj@csr.nih.gov.
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group, Macromolecular Structure and
Function E Study Section.
Date: October 14, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle, NW.,
Washington, DC 20005.
Contact Person: Nitsa Rosenzweig, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1102, MSC 7760, Bethesda, MD
20892. (301) 435-1747. rosenzweign@csr.nih.gov.
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group, Cardiovascular Differentiation and
Development Study Section.
Date: October 14-15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Churchill Hotel, 1914 Connecticut Avenue, NW.,
Washington, DC 20009.
Contact Person: Maqsood A Wani, PhD, DVM, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136, MSC 7814, Bethesda, MD
20892. 301-435-2270. wanimaqs@csr.nih.gov.
Name of Committee: Immunology Integrated Review Group, Innate
Immunity and Inflammation Study Section.
Date: October 14-15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Old Town Alexandria, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Tina McIntyre, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4202, MSC 7812, Bethesda, MD 20892. 301-594-
6375. mcintyrt@csr.nih.gov.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group, Acute Neural Injury and Epilepsy Study
Section.
Date: October 14-15, 2010.
Time: 8 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Plaza Hotel, 10 Thomas Circle, NW.,
Washington, DC 20005.
Contact Person: Seetha Bhagavan, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892. (301) 237-
9838. bhagavas@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Development Methods of In Vivo Imaging and Bioengineering
Research.
Date: October 14-15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
[[Page 54640]]
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Behrouz Shabestari, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106, MSC 7854, Bethesda, MD
20892. (301) 435-2409. shabestb@csr.nih.gov.
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group, Molecular Oncogenesis Study Section.
Date: October 14-15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza Old Town Alexandria, 901 North Fairfax
Street, Alexandria, VA 22314.
Contact Person: Nywana Sizemore, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6204, MSC 7804, Bethesda, MD 20892. 301-435-
1718. sizemoren@csr.nih.gov.
Name of Committee: Cell Biology Integrated Review Group, Nuclear
and Cytoplasmic Structure/Function and Dynamics Study Section.
Date: October 14-15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The St. Regis Washington, DC, 923 16th and K Streets,
NW., Washington, DC 20006.
Contact Person: David Balasundaram, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892. 301-435-1022. balasundaramd@csr.nih.gov.
Name of Committee: Infectious Diseases and Microbiology
Integrated Review Group, Pathogenic Eukaryotes Study Section.
Date: October 14-15, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Tera Bounds, DVM, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198, MSC 7808, Bethesda, MD
20892. 301-435-2306. boundst@csr.nih.gov.
Name of Committee: Biology of Development and Aging Integrated
Review Group, International and Cooperative Projects--1 Study
Section.
Date: October 14, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Nikko San Francisco, 222 Mason Street, San
Francisco, CA 94102.
Contact Person: Dan D. Gerendasy, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5132, MSC 7843, Bethesda, MD
20892. 301-594-6830. gerendad@csr.nih.gov.
Name of Committee: Immunology Integrated Review Group, Immunity
and Host Defense Study Section.
Date: October 14-15, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Old Town Alexandria, 1767 King Street, Alexandria,
VA 22314.
Contact Person: Patrick K. Lai, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2215, MSC 7812, Bethesda, MD 20892. 301-435-
1052. laip@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Therapeutic Approaches to Genetic Diseases.
Date: October 14, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Avenue, NW., Washington,
DC 20037.
Contact Person: Michael K. Schmidt, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2214, MSC 7890, Bethesda, MD
20892. (301) 435-1147. mschmidt@mail.nih.gov.
Name of Committee: Immunology Integrated Review Group, Cellular
and Molecular Immunology--B Study Section.
Date: October 14-15, 2010.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Magnificent Mile Downtown Chicago, 165 E.
Ontario Street, Chicago, IL 60611.
Contact Person: Betty Hayden, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4206, MSC 7812, Bethesda, MD 20892. 301-435-
1223. haydenb@csr.nih.gov.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group, Genetic Variation and Evolution Study Section.
Date: October 14-15, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: The River Inn, 924 25th Street, NW., Washington, DC
20037.
Contact Person: David J. Remondini, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210, MSC 7890, Bethesda, MD
20892. 301-435-1038. remondid@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Member Conflict: SAT and BTSS Study Sections.
Date: October 14, 2010.
Time: 2 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting).
Contact Person: Roberto J. Matus, MD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5108, MSC 7854, Bethesda, MD 20892. (301) 435-
2204. matusr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 1, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-22311 Filed 9-7-10; 8:45 am]
BILLING CODE 4140-01-P
